Biomagnetics Diagnostics Corp. (BMGP)

0.0000 0.0000 (0.00%) At close: 03:16PM EDT

Biomagnetics Diagnostics Corp.

8864 Greenback Lane
Suite E
Orangevale, CA 95662
United States
916-987-7078
https://www.biomagneticsbmgp.com

Sector(s): 
Industry: 
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Clayton M. Hardman	Founder, CEO, President, Acting CFO, Secretary & Director	N/A	N/A	1944
Mr. Paul Clayton Hardman	Chief Operating Officer	N/A	N/A	N/A
Dr. Jose Manuel Lopez Portillo	Director and Director of Strategic Alliances & Government Affairs for Mexico	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Biomagnetics Diagnostics Corporation, a medical device and biotechnology company, designs, patents, and markets diagnostic equipment and immunoassays, and other biotechnologies. Its products include High Throughput Screening–Magnetic Testing Platform (HTS-MTP) to provide qualitative and quantitative results from a single test by detecting the target virus through measuring the magnetic field of micro-particles bonded to the virus in a fraction of the time; and Integrated Optical Biosensor System that is based on protein-receptor binding, which brings two or more optically tagged receptors into close proximity using planar optical waveguides, and triggers fluorescence changes identified by tiny on-board detectors. Biomagnetics Diagnostics Corporation has a licensing and collaborative research and development agreement with Las Alamos National Security LLC for Integrated Optical BioSensor. The company was founded in 1997 and is based in Orangevale, California.

Corporate governance

Biomagnetics Diagnostics Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.